Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...
HIGHS Absolutely silent inside, highest level of fit and finish, makes the same high-end statement as gas-powered Rolls-Royces. LOWS Less driving range than other high-dollar EVs, road manners a bit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback